† Study has passed its completion date and status has not been verified in more than two years.
A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels
Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease
IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease
Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas